Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 110 for “"TSC2"”.
-
Die TSC2 - mTOR Achse bei der diabetischen Kardiomyopathie
… von mTOR, tuberous-sclerosis complex 2 (TSC2), so modifiziert, dass es an Position S1365 eine Hyperphosphorylierung (TSC2SE, Serin (S) zu Glutamat (E) -Mutation) bzw. Hypophosphorylierung (TSC2SA, S zu Alanin (A)-Mutation) imitiert. Durch die Mutation des S1365 zu Glutamat (TSC2SE) führt …
-
Characterization of cellular abnormalities due to loss of TSC2
… and autism. TSC results from mutation in TSC1 or TSC2, which together form a complex that serves as a negative regulator of protein kinase mTORC1, a key regulator of cell growth and metabolism. Thus, cells with diminished TSC1:TSC2 function display elevated mTORC1 signaling, leading to the …
-
The Role of TSC2 and Deptor in Fetal Cortical Development
… that results form mutations in the TSC1 or TSC2 genes. TSC is a multisystem hamartoma syndrome with manifestations in the brain, heart, lungs, kidney, skin and eyes. Neurologically, TSC patients may exhibit severe epilepsy, cognitive disabilities, and autism spectrum disorders. TSC1 and TSC2 …
-
Atm Signaling to Tsc2: Mechanisms and Implications For Cancer Therapy
… to mTORC1 to induce autophagy via the LKB1-AMPK-TSC2 pathway. Targeting dysregulation of mTORC1 in Atm-deficient mice, which succumb to lymphomagenesis within 3-4 months of age with daily administration of rapamycin, could significantly extend survival and cause regression of tumors, suggesting …
-
Loss of Tsc2 Results in Abnormal Postnatal Neurogenesis and Striatal Hamartomas
… from the inactivation of either the Tsc1 or Tsc2 gene and is considered the main driver of symptoms in the developmental disorder Tuberous Sclerosis Complex (TSC). TSC is characterized by congenital growths that form in multiple organ systems, including the brain. In TSC, the brain has …
-
TSC2-mTORC1 signaling in murine Heart failure with preserved Ejection fraction (HFpEF)
… HFpEF unklar. Der Tuberöse-Sklerose-Komplex 2 (TSC2) ist ein negativer Regulator von mTORC1, der Wachstum, Stoffwechsel, Proteinsynthese und Autophagie koordiniert. In dieser Studie untersuchen wir die Rolle der TSC2-mTORC1-Signalachse bei HFpEF und ihre Auswirkungen auf metabolische Prozesse in …
-
STUDIO BIOCHIMICO E FARMACOLOGICO DI CELLULE MUSCOLARI LISCE ISOLATE DA TESSUTI DI PAZIENTI AFFETTI DA TSC2 E LAM. MODIFICAZIONI EPIGENETICHE DEL GENE TSC2 NELLA PATOGENENESI DELLA TSC E DELLA LAM.
… a genetic disease caused by mutation in TSC1 or TSC2 genes. TSC2 cells form hamartomas and might invade lungs causing the fatal diseases LAM. From an angiomylipoma (AML) of a TSC male patient we isolated a TSC2 smooth muscle (ASM) population. The growth of these cells was EGF-dependent. They …
-
Inhibition of Class I HDACs Blunts Cardiac Hypertrophy via TSC2-Dependent mTOR Repression
… as well as decreased mTOR activity. Tuberin (TSC2) is a component of the tuberin-hamartin complex, which inhibits mTOR. We found that inhibition of class I HDACs by either genetic knockdown or using small molecules increased expression of TSC2 in both NRVMs and embryonic stem cell-derived …
-
Mathematical Modeling Reveals That G2/M Checkpoint Override Creates A Therapeutic Vulnerability In Tsc2-Null Tumors
… pathway delayed G2/M checkpoint recovery, while TSC2-null cells with hyperactivity of mTORC1 exhibited the opposite results. Furthermore, our mechanistic study revealed that mTOR signaling pathway controls a transcriptional program of mitotic entry through regulating histone lysine demethylase …
-
Mathematical Modeling Reveals That G2/M Checkpoint Override Creates A Therapeutic Vulnerability In Tsc2-Null Tumors
… pathway delayed G2/M checkpoint recovery, while TSC2-null cells with hyperactivity of mTORC1 exhibited the opposite results. Furthermore, our mechanistic study revealed that mTOR signaling pathway controls a transcriptional program of mitotic entry through regulating histone lysine demethylase …
-
Roles of the TSN1 and TSC2 Genes in Conferring Susceptibility of Durum Wheat to Tan Spot and Septoria Nodorum Blotch
… which recognize host sensitivity genes Tsn1 and Tsc2, respectively. In this research, a tetraploid recombinant inbred line population was evaluated for reaction to the Ptr ToxA and Ptr ToxB-producing isolates 86-124 (race 2) and DW5 (race 5). The results indicated that a compatible Tsc2-Ptr ToxB …
-
Characterization of a Tuberous Sclerosis Complex 2 Variant and its Interaction Involving the Ras-Related Protein Rheb
… an interaction with Tuberous Sclerosis Complex2 (TSC2), a GTPase activating protein (GAP). Upon interaction, TSC2 stimulates Rheb GTP hydrolysis and diminishes the mammalian target of rapamycin (mTOR) pathway. The mTOR pathway is involved in proteins synthesis, cell cycle, and signaling. Mutation …
-
Therapeutic targeting of DGKA-mediated macropinocytosis in lymphangioleiomyomatosis
… by mutations in tumor suppressor genes TSC1 and TSC2. Spontaneous biallelic mutations in these genes can give rise to sporadic LAM. Mammalian target of rapamycin complex I (mTORC1), a master regulator of cellular anabolic metabolism is hyperactivated in LAM cells. Upregulation of protein …
-
Modeling and Therapeutic Development for the Tuberous Sclerosis Related Neoplasm Lymphangioleiomyomatosis
… the loss of heterozygosity in either the TSC1 or TSC2 genes. However, their physical manifestations are vastly different and can generally be classified as being either neurological (TSC) or mesenchymal (TSC & LAM; referred to herein as LAM for simplicity) in origin. In this study, I present a …
-
The role of the lysosome and transcription factor EB in tuberous sclerosis complex
… loss-of-function mutations of either the TSC1 or TSC2 genes. It is a multisystemic disorder with manifestations in several organs including the lungs, kidneys, brain, skin, and heart. Loss of either TSC1 or TSC2 causes hyperactivation of the mechanistic target of rapamycin complex 1 (mTORC1) …
-
The role of the TSC-complex in selective neuronal vulnerability in Alzheimer’s disease
… partner and molecular chaperone, Tuberin (TSC2), and that it would be located either to the lysosomal compartment or granulovacuolar degeneration (GVD) bodies. We first investigated the distribution of lysosome-associated membrane protein (LAMP1)- and GVD-positive pyramidal neurons in the …
-
The role of the neuronal environment in neurodevelopment and circuit formation in Tuberous Sclerosis Complex
… Complex (TSC)</i> results from <i>TSC1</i> or <i>TSC2</i> gene mutations with hyperactivation of the <i>mechanistic target of rapamycin complex 1 (mTORC1)</i>. TSC is characterised by benign hamartomas in multiple organs including the brain and neurological symptoms are often amongst the most …
-
High-throughput drug screen to identify compounds working selectively and synergistically with CQ to inhibit proliferation of TSC-2 deficient cells
… by a germ line mutation in the genes TSC1 and TSC2. Patients with the disease tend to suffer from benign tumors of the brain, heart, kidneys, skin, and other organs that contain giant cells. Although mTORC1 inhibitors (rapamycin and rapalogs) are often used to treat TSC because of their …
-
RHEB DYNAMICS ON LYSOSOMAL MEMBRANES DETERMINES MTORC1 ACTIVITY AFTER LOSS OF P53 OR ACTIVATION OF AMPK
… of p53. This activation involves the loss of TSC2 from lysosomal membranes, the site of mTORC1 activation by Rheb. We demonstrate that loss of lysosomal TSC2 increased the levels of lysosomal Rheb. Control of mTORC1 was restored by overexpression of TSC2, which correlated with decreased …
Page 1 of 6